Helder André
- Ophthalmology top 1%
- Retinal Diseases and Treatments 29
- Glaucoma and retinal disorders 21
- Ocular Oncology and Treatments 4
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism 8
- Neurology top 10%
-
- Angiogenesis and VEGF in Cancer 14
- Retinal Development and Disorders 13
- CRISPR and Genetic Engineering 5
-
- Corneal Surgery and Treatments 4
Helder André
60 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 92
- Ophthalmology 427
- Cancer Research 200
- Neurology 83
- Molecular Biology 602
- Radiology, Nuclear Medicine and Imaging 198
Countries citing papers authored by Helder André
This map shows the geographic impact of Helder André's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helder André with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helder André more than expected).
Fields of papers citing papers by Helder André
This network shows the impact of papers produced by Helder André. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helder André. The network helps show where Helder André may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Helder André, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 7 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 0 | |
| 8 | 2023 | 2 | |
| 9 | 2023 | 8 | |
| 10 | 2023 | 1 | |
| 11 | 2023 | 1 | |
| 12 | 2020 | 71 | |
| 13 | 2020 | 27 | |
| 14 | 2020 | 47 | |
| 15 | 2019 | 60 | |
| 16 | 2019 | 6 | |
| 17 | Microphthalmia-associated transcription factor (Mitf) modulates autophagy in mouse primary RPE cells | 2018 | 1 |
| 18 | 2018 | 4 | |
| 19 | 2016 | 22 | |
| 20 | 2008 | 19 |
About Helder André
Helder André is a scholar working on Ophthalmology, Cancer Research and Immunology and Allergy, having authored 64 papers that have together received 1.1k indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (29 papers), Glaucoma and retinal disorders (21 papers), Angiogenesis and VEGF in Cancer (14 papers), Retinal Development and Disorders (13 papers), Cancer, Hypoxia, and Metabolism (8 papers), CRISPR and Genetic Engineering (5 papers), Ocular Oncology and Treatments (4 papers) and Corneal Surgery and Treatments (4 papers). The work is most often cited by research in Ophthalmology (427 citations), Cancer Research (200 citations) and Neurology (83 citations). Helder André has collaborated with scholars based in Sweden, Spain and Italy. Frequent co-authors include Anders Kvanta, Monica Aronsson, Effat Alizadeh, Hammurabi Bartuma, Sandra Petrus-Reurer, Teresa Pereira, Fredrik Lanner, Emma Lardner, Kari Alitalo and Álvaro Plaza Reyes. Their work appears in journals such as Acta Ophthalmologica, Investigative Ophthalmology & Visual Science, Experimental Eye Research, The FASEB Journal and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.